Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression

Marissa Shrader, Maria Simona Pino, Laura Lashinger, Menashe Bar-Eli, Liana Adam, Colin P.N. Dinney, David J. McConkey

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression'. Together they form a unique fingerprint.

Medicine & Life Sciences